The Pfizer-BioNTech vaccine has now proved 95% effective in preventing coronavirus and has met the safety criteria needed for emergency authorisation, the firms have said.
Health Secretary Matt Hancock has said that, pending authorisation, the NHS will be ready to roll them out to the most vulnerable from 1 December.
There’s been promising results for people aged over sixty five, who can be hit hard by coronavirus.